12:00 – 1:
00 PM EDT
Rathindra (Babu) DasGupta, PhD – University of Wisconsin-Milwaukee
Errol Arkilic, PhD – M34 Capital
Christie A. Canaria, PhD – National Cancer Institute
$150 Members/$225 Non-Members
Join us as we look back on the impact the
I-Corps customary discovery methodology has had on the commercialization of university research.
Participants will have the chance to learn from three I-Corps Program Directors
who will share their personal observations and perspectives while addressing the impact of I-Corps in the last 10 years.
This session will begin with a presentation on the genesis of I-Corps by looking at the founding principles that led to the formation of the NSF program.
I-Corps applicants and administrators alike will benefit from attending this session. I-Corps applicants will learn how to prepare competitive proposals, understand what makes a good commercialization team and discover what universities can do to make their programs, and their startup teams, stronger. Administrators will learn how they can successfully run sites through a discussion of what techniques have worked well, what things haven’t worked as expected, and what lessons the directors have taken away pre- and post-COVID.
Next, participants will hear about the cooperative, interagency partnership that led to the start of the I-Corps at NIH Program. Through success stories and real life-clinical impacts, you’ll discover the lasting effects of this program and understand the differences between the NSF and NIH curriculum. Finally, participants will hear the university perspective of leveraging the program. Hear the impact of entrepreneurship training and success factors for academic spinoffs and how I-Corps can be applied in other areas.